The National Center for Advancing Translational Sciences (NCATS) is seeking a Senior Scientist to serve as the Director of the Early Translation Branch (ETB), Division of Pre-Clinical Innovation (DPI). The ETB Director is responsible for planning and directing a comprehensive program in the discovery of pharmacological tools to probe the function of the human genome and to understand and improve the processes underlying early discovery.
BASIC QUALIFICATIONS:
A. Have completed the requirements for a bachelor's degree in a biological science, agriculture, natural resource management, chemistry, or related disciplines appropriate to this position, from an accredited college or university;
OR
B. Have a combination of experience and education which includes courses comparable to a major in a biological science, agriculture, natural resource management, chemistry or related disciplines appropriate to this position, AND have appropriate experience or additional education which demonstrates similarly appropriate skills or abilities needed to perform the duties of this position.
ADDITIONAL QUALIFICATIONS: In addition to meeting the education requirements, you must demonstrate in your resume at least one (1) year of qualifying experience equivalent to at least the GS-14 level in the Federal service obtained in either the private or public sector, performing the following types of tasks: directing and managing a large scientifically diverse research program in comprehensive early translational science; working in a multi-disciplinary research environment related to the pre-clinical development of various therapeutic modalities; consolidating research information to generate new strategies and approaches in collaboration with other scientists; overseeing therapeutic development of rare diseases, including small molecule, biologic, and gene therapy approaches; and accomplishing early discovery through the pre-clinical development of therapeutics and diagnostics to proof-of-concept in humans.
IDEAL CANDIDATE:
- Strong background in biomedical sciences as well as a record of accomplishment in academic and/or biopharmaceutical pre-clinical translation, with demonstrated experience leading multidisciplinary research groups in technology and therapeutic/diagnostic/intervention discovery.
- High-level expertise in planning and directing a comprehensive program in early translational science, from target validation through the discovery of pharmacological tools to probe the function of the human genome.
- Proven ability to creatively approach and solve complex technical problems in the preclinical development space.
- Extensive research training and experience in academia, the biopharmaceutical industry, and/or the government. Recognized nationally and internationally for scientific leadership.
- Expertise and accomplishment in multiple aspects of preclinical translation from early discovery through the preclinical development of therapeutics and/or diagnostics to proof-of-concept in humans.
- Has broad and first-hand knowledge of the field of rare disease therapeutic development, including small molecule, biologic, and gene-therapy approaches.
- Evidence of commitment to Diversity, Equity, Inclusion, and Accessibility (DEIA).
#J-18808-Ljbffr
